Sangamo Therapeutics Aktie
0,43
EUR
+0,02
EUR
+5,24
%
0,49
USD
-0,04
USD
-6,62
%
Werbung
Sangamo Therapeutics Aktie Analyse
| 26.08.19 | Sangamo Therapeutics Buy | H.C. Wainwright & Co. | |
| 24.04.15 | Sangamo Therapeutics Outperform | BMO Capital Markets | |
| 08.10.09 | Sangamo Therapeutics outperform | Leerink Swann LLC | |
| 26.08.09 | Sangamo Therapeutics market outperform | JMP Securities LLC | |
| 23.02.09 | Sangamo Therapeutics outperform | Leerink Swann LLC | |
| 11.11.08 | Sangamo Therapeutics outperform | Leerink Swann LLC | |
| 16.10.08 | Sangamo Therapeutics buy | Merriman Curhan Ford & Co | |
| 26.08.08 | Sangamo Therapeutics outperform | Leerink Swann LLC | |
|
Werbung
|
|||
| 07.02.08 | Sangamo Therapeutics strong buy | JMP Securities | |
| 06.11.07 | Sangamo Therapeutics strong buy | JMP Securities | |
| 26.10.07 | Sangamo Therapeutics strong buy | JMP Securities | |
| 18.10.07 | Sangamo Therapeutics buy | Pacific Growth Equities | |
| 01.12.06 | Sangamo Therapeutics market outperform | JMP Securities | |
| 24.08.06 | Sangamo Therapeutics Buy | Cantor Fitzgerald | |
Werbung
Werbung